Taysha Gene Therapies News

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Donenberg Phillip B.

May 31 16:28 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Long Alison S

May 31 16:28 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Stalfort John A III

May 31 16:27 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Sepp-Lorenzino Laura

May 31 16:21 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.6%),VHCP Co-Investment Holdings III, LLC(5.6%), etc.

Feb 14 20:48 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.

Feb 14 17:31 ET

Taysha Gene Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(9.8%),Roderick Wong, M.D.(9.8%)

Feb 14 07:11 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(1.6%),TCG Crossover Fund I, L.P.(1.6%), etc.

Feb 9 16:31 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.002%),Abigail P. Johnson(12.002%)

Feb 9 09:56 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Alam Kamran

Feb 6 16:43 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Alam Kamran

Jan 4 00:00 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Nagendran Sukumar

Jan 4 00:00 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Nolan Sean P.

Jan 4 00:00 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Alam Kamran

Dec 18, 2023 16:50 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Nagendran Sukumar

Dec 18, 2023 16:47 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Nolan Sean P.

Dec 18, 2023 16:46 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-10% Owner Manning Paul B

Nov 20, 2023 07:35 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Long Alison S

Nov 3, 2023 16:41 ET

Taysha Gene Therapies | 3: Initial statement of beneficial ownership of securities-Director Long Alison S

Nov 3, 2023 16:40 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.962%),Abigail P. Johnson(14.962%)

Sep 11, 2023 08:23 ET